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Tbjective: Repair of Ebstein anomaly and impaired right ventricular function pose
hallenges for the cardiac surgeon. The bidirectional cavopulmonary shunt may
mprove early outcomes. We reviewed our experience with the 1.5-ventricle repair
n this patient population.
ethods: Between July 1999 and March 2006, 169 patients underwent opera-
ions to repair Ebstein anomaly. Fourteen patients had a bidirectional cavopul-
onary shunt constructed. The median age at operation was 6 years (17
onths-57.8 years). All of the patients had severe Ebstein anomaly with dilated
ight-sided chambers and/or right ventricular dysfunction. The mean left ven-
ricular ejection fraction was 54.5% (range 35%–72%). Three patients were
nitially referred for heart transplantation, and the bidirectional cavopulmonary
hunt allowed a conventional repair.
esults: Procedures included bidirectional cavopulmonary shunting (14), tricuspid
alve replacement (11), tricuspid valve repair (2), and right ventricular resection (3).
hunting was planned preoperatively in 9 patients; the indication in 5 other patients
as hemodynamic instability after separation from cardiopulmonary bypass. One
atient died of multiple organ failure. Median follow-up in 10 patients was 18
onths (3 months-6.5 years). The preoperative left ventricular ejection fraction of
ess than 50% improved in 3 patients to greater than 50% postoperatively.
onclusions: The 1.5-ventricle repair can be utilized in patients with severe Ebstein
nomaly and impaired right ventricular function who are at high risk for surgical
reatment. We believe the bidirectional cavopulmonary shunt may be considered as
planned procedure, as an intraoperative salvage maneuver, or as an alternative to
ardiac transplantation in selected patients.
he surgical management of patients with severe anatomic and functional
Ebstein anomaly remains a significant challenge. The timing and choice of
treatment may depend on the patient’s clinical presentation, the morphology
f the tricuspid valve (TV), the presence of a right-to-left shunting through an atrial
eptal defect, the severity of right-sided cardiac chamber dilation, and the degree of
ight (RV) and left ventricular (LV) dysfunction.
The bidirectional cavopulmonary shunt (BCPS), or “one and one-half (1.5)
entricle repair” has been used when the RV was judged not capable of
upporting the pulmonary circulation.1,2 Diversion of the superior vena caval
lood to the pulmonary arteries reduces the RV preload, and this may decrease
V work.1 In patients with Ebstein anomaly and impaired RV function, the
CPS may facilitate surgical treatment by unloading the RV and providing
reload to the LV. The 1.5-ventricle repair may be an alternative for patients
ith severe Ebstein anomaly and an impaired RV who are at high risk fortandard surgical treatment.
he Journal of Thoracic and Cardiovascular Surgery ● Volume 133, Number 5 1303
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DThe purpose of this report was to review our institutional
xperience with the surgical treatment of patients with Eb-
tein anomaly and an impaired RV who had a BCPS as part
f their repair.
aterials and Methods
atients
e conducted this review as part of a larger study approved by the
nstitutional Review Board of the Mayo Clinic Foundation on the
atural history of treated patients with Ebstein anomaly. Between
Abbreviations and Acronyms
BCPS bidirectional cavopulmonary shunt
LV  left ventricle(ular)
LVEF left ventricular ejection fraction
PAP  pulmonary artery pressure
RV  right ventricle(ular)
TV  tricuspid valve
ABLE 1. Patient demographics, clinical presentations, an
atient Age Clinical presentation
1 17 mo Biventricular failure; shock; atrial flutter
2 18 mo Cyanosis; decreased stamina
3 23 mo Asymptomatic ASD
4 46 mo Decreased activity and energy
5 57 mo Cyanosis; decreased stamina
6 59 mo Progressive fatigue
7 70 mo Cyanosis; moderate aortic stenosis
8 73 mo Asymptomatic RV enlargement
9 100 mo Cyanosis
10 154 mo Fatigue; cyanosis
11 23.2 y Dyspnea; atrial arrhythmias; transplantation
waiting list
12 48 y Dyspnea; atrial arrhythmias; transplantation
assessment
13 56.2 y Stroke with ASD
14 57.8 y Dyspnea; cyanosis; atrial fibrillation;
transplantation assessment
SD, Atrial septal defect; BCPS, bidirectional cavopulmonary shunt; ECMO
eft pulmonary artery; MBTS, modified Blalock–Taussig shunt; PFO, paten
eplacement.
304 The Journal of Thoracic and Cardiovascular Surgery ● Mapril 18, 1972, and March 30, 2006, 642 patients with a diagnosis
f Ebstein anomaly underwent open cardiac operations at the
ayo Clinic in Rochester, Minnesota.
From July 1, 1999 to March 30, 2006, 169 patients with Ebstein
nomaly underwent surgical treatment; 14 of these had a BCPS
nd form the cohort of this study. Their medical records were
eviewed. Eight of the 14 operations were performed in the last 12
onths of the review period. There were 10 male and 4 female
atients, and their ages ranged from 17 months to 57.8 years (mean
6.9 years; median 6 years).
The youngest patient (17 months) was in shock owing to
iventricular failure; RV enlargement resulted in LV failure
ecause of inadequate preload and significant compression from
he massive RV. In the younger group of patients (patients 2
hrough 10, Table 1), whose ages ranged from 18 months to 12.8
ears, the most common presentation was cyanosis, fatigue, or
ecreased stamina. Two children (patients 3 and 8) were free of
ymptoms. Dyspnea was the predominant clinical presentation in
he adult age group.
Three adult patients (patients 11, 12, and 14) were initially
eferred for heart transplantation; patient 11 was placed on the
imary operations
Primary procedure(s) Other procedures
R 27 mm PFO closure; isthmus
cryoablation; right reduction
atrioplasty; BCPS; ECMO; open
chest
R 21 mm; BCPS ASD closure; interruption MBTS;
dilatation LPA; resection
subpulmonary tissue
SD closure
re-repair; BCPS RV resection; right reduction
atrioplasty
R 25 mm; BCPS ASD closure; right reduction
atrioplasty
R 27 mm Right reduction atrioplasty; BCPS
iled TV repair; TVR 25 mm;
aortic valvotomy
ASD closure; right reduction
atrioplasty; BCPS; open chest
repair; BCPS Right reduction atrioplasty
R 25 mm; BCPS ASD closure; RV resection; right
reduction atrioplasty
R 35 mm ASD closure; right reduction
atrioplasty; BCPS; open chest
R 29 mm; BCPS Modified maze
R 31 mm BCPS; modified maze; RV
resection; right reduction
atrioplasty
SD closure; TVR 33 mm Open chest
R 31 mm BCPS; PFO closure; modified
maze; right reduction
atrioplasty; IABP; open chest
acorporeal membrane oxygenation; IABP, intra-aortic balloon pump; LPA,
men ovale; RV, right ventricular; TV, tricuspid valve; TVR, tricuspid valved pr
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Daiting list for transplantation (Table 1). After our evaluation,
hese 3 patients were treated with a conventional operation and a
CPS.
Prior operations had been performed elsewhere in 4 patients.
atients 2 and 3 were implanted with modified Blalock–Taussig
hunts as infants, and 1 child (patient 4) had undergone a TV repair
nd modified maze procedure. One adult (patient 11) had a TV
eplacement and atrial septal defect closure as a teenager.
Preoperative diagnostic testing included chest radiography, elec-
rocardiography, and comprehensive transthoracic echocardiographic-
oppler examination in all patients. Echocardiography was used to
onfirm the diagnosis of Ebstein anomaly and to determine RV and
V size and function, the degree of TV regurgitation, and the
otential for TV repair. Hemodynamic cardiac catheterization was
erformed selectively.
All patients had anatomically severe Ebstein anomaly with
ignificant abnormalities and displacement of the TV. Severe RV
ilation and dysfunction were present in 11 patients. Two patients
ad only moderate RV dilation but severe RV dysfunction. In these
3 patients, the RV fractional area change was 19% (range 13%-
9%). One child had hypoplasia of the anatomic RV with moderate
V dysfunction (fractional area change of 37%). TV regurgitation
as graded as severe in 12, moderate in 1, and mild in 1. Patient
had an atrial septal defect and severe RV enlargement but only
ild TV regurgitation. Patient 8 had progressive RV enlargement
nd severe TV regurgitation.
The mean LV ejection fraction (LVEF) was 54% (range 35%-
2%) and the mean LV fractional area change was 45% (range
2%-58%). In patient 1, the LVEF could not be estimated because
f limited echocardiographic views as the LV was underfilled and
ompressed by the RV. Three patients (patients 10, 12, and 14) had
n LVEF of less than 50%. Patient 11 initially had a depressed
VEF; however, after his medication regimen was adjusted and
he ventricular response to his atrial tachyarrythmias was con-
rolled, his preoperative LVEF improved significantly. Patient 12
ad a preoperative hemodynamic catheterization; his mean pulmo-
ary artery pressure (PAP) was 27 mm Hg and his pulmonary
apillary wedge pressure was 24 mm Hg, resulting in a transpul-
onary gradient of 3 mm Hg.
perative Technique
tandard surgical techniques of sternotomy, aortic and bicaval
annulations, cardiopulmonary bypass, and myocardial protection
ere used. All extracardiac shunts were interrupted. Closure of
nteratrial communications was either by direct suture or by au-
ologous pericardial patch. Maze procedures and their modifica-
ions were performed in patients (n  3) with a history of atrial
achyarrhythmias using techniques previously described.3 The in-
erior wall of the RV was resected (n 3) when it was noted to be
hin, transparent, and dyskinetic. The resection included an ellipse
rom the base to the apex; this effectively brought the acute margin
f the RV closer to the posterior descending coronary artery. Right
eduction atrioplasty was routinely performed. When a TV re-
lacement was done (n  11), the conduction tissue and right
oronary artery were protected.4 All valve replacements in this
eries were performed with stented porcine bioprostheses. TV
epair techniques with modifications have been described previ-
usly.5 The BCPS (n  14) was performed by division of the a
The Journal of Thoracicuperior vena cava at the junction with the right atrium followed
y an end-to-side anastomosis to the superior surface of the right
ulmonary artery; the azygos vein was routinely divided.
esults
he procedures performed are outlined in Table 1. As a
eflection of the advanced severity of the Ebstein anomaly
n this group, a TV replacement was required in 11 patients.
In 9 patients, the potential need for a BCPS was men-
ioned in the preoperative record and reflected concerns
bout RV dysfunction. These were referred to as “planned”
rocedures. In the other 5 patients, the BCPS was performed
s a salvage procedure owing to RV failure.
In patients with a normal LVEF, intraoperative left atrial
ressures or PAPs were not routinely measured. Neverthe-
ess, patients 2 and 11 had an average left atrial pressure of
mm Hg and patient 13 had a mean PAP of 16 mm Hg. In
atients with depressed LVEF, these pressures were mea-
ured intraoperatively to confirm that the patient would
olerate the BCPS. Patients 10, 12, and 14 had a mean left
trial pressure of 7 mm Hg, a mean PAP of 15 mm Hg, and
mean transpulmonary gradient of 7 mm Hg.
Five patients had delayed sternal closure, 2 children
equired extracorporeal membrane oxygenator support,
nd 2 adults required intra-aortic balloon counterpulsa-
ion (Table 2). One patient required dialysis. One child
equired a thrombectomy of the TV bioprosthesis at the time
f removal of extracorporeal membrane oxygenator sup-
ort. One patient required a permanent epicardial pacing
ystem for complete heart block.
There was 1 hospital death. Patient 7 was a 5-year-old
irl who also had moderate aortic stenosis. She underwent
n aortic valvotomy, an atrial septal defect closure, and an
nsuccessful TV repair that necessitated TV replacement at
he initial operation. Intraoperatively, the RV was severely
nlarged and dysfunctional after separation from cardiopul-
onary bypass; thus a BCPS was created. The residual
ean gradient across the aortic valve after valvotomy was 8
o 10 mm Hg and the LV function was normal. She required
xtracorporeal membrane oxygenator support to leave the
perating room. Because her condition failed to improve, a
enestrated extracardiac conduit Fontan procedure was per-
ormed. This was not successful and the Fontan was taken
own; she was left with a 1.5-ventricle circulation and an
dditional aortopulmonary shunt. She died 14 days after the
nitial operation of multiple organ failure. Postmortem
xamination demonstrated evidence of unrecognized fungal
epticemia that contributed to multiple organ failure.
In all 3 patients with preoperative LVEF less than 50%,
he postoperative LVEF at hospital dismissal was greater
han 50%.
The length of stay after the initial operation ranged from
to 28 days (mean 9.8 days; median 7.5 days). Follow-upfter hospital dismissal was available in 10 patients. This
and Cardiovascular Surgery ● Volume 133, Number 5 1305
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Danged from 3 months to 6.5 years (mean 25 months;
edian 18 months). Nine patients reported no functional
imitations at the time of their last follow-up. One patient
patient 14) reported a significant improvement since sur-
ery, although still having dyspnea when not receiving
iuretic therapy. Patients 8 and 9 reported upper extremity
nd facial swelling, but this was not problematic.
Echocardiographic follow-up was available in 4 patients
mean 11 months; range 6-15 months). In 3 patients, the RV
nd LV functions did not deteriorate or improve. Only 1
atient (patient 14) had a significant improvement in LVEF
rom 40% to 60%, yet a significant deterioration in RV
ractional area change from 16% to 6%. This patient re-
ains symptomatic.
iscussion
he diversion of superior vena caval blood to the pulmonary
rteries decreases the volume load on the RV by approxi-
ately one half in infants and one third in adults, and it
hereby may decrease RV work.6 The BCPS may be bene-
cial in patients undergoing surgical interventions for con-
enital heart lesions when hemodynamic performance is
ompromised by a failing pulmonary ventricle.2 Postoper-
tive RV failure is associated with increased early mortality
n surgically treated patients with Ebstein anomaly,7 and an
nlarged heart is also a risk factor for mortality.8 Chauvaud
nd associates7 and Chauvaud9 believe that the addition of
BCPS to the surgical treatment of patients at risk of RV
ailure decreases operative mortality. The BCPS accom-
lishes two important things in the setting of RV failure: (1)
t reduces the venous return to the enlarged, dysfunctional
ABLE 2. Postoperative course and follow-up after hospit
atient Course
1 ECMO; operative thrombectomy of TV; delayed stern
2 Uneventful
3 Uneventful
4 Uneventful
5 Uneventful
6 Uneventful
7 Open chest; ECMO; conversion to Fontan circulation
central aortopulmonary shunt; bleeding; dialysis; w
8 Uneventful
9 Uneventful
10 Delayed chest closure; anticoagulation for decrease
leaflet mobility
11 Uneventful
12 IABP
13 Bleeding; RV failure; BCPS; IABP; delayed sternal c
14 IABP; delayed sternal closure; complete heart block
placement
CPS, Bidirectional cavopulmonary shunt; ECMO, extracorporeal membr
ultiple organ failure; RV, right ventricular; TV, tricuspid valve.V and (2) it optimizes preload to the LV. o
306 The Journal of Thoracic and Cardiovascular Surgery ● MaA small number of cases describing the use of a BCPS as
n adjunct to the surgical treatment of Ebstein anomaly can
e found within series of outcome analyses of the 1.5-
entricle repair or within series of the surgical treatments
nd outcomes of patients with Ebstein anomaly.1,10-14 How-
ver, little emphasis has been placed on the clinical or
chocardiographic characteristics of these patients; the ra-
ionale for the construction of the BCPS is only mentioned
riefly; and late outcomes have not been reported. There are
ew case series that exclusively report on the use of the
CPS with Ebstein anomaly.7,15,16
BCPS has been used infrequently in patients with
bstein anomaly and has been used only recently at our
nstitution. Since we have gained experience with the sur-
ical management of Ebstein anomaly, we have considered
he use of the BCPS as an adjunctive treatment for those
atients who were considered to be at high risk for a
onventional operation. In our experience, the overwhelm-
ng majority of patients with Ebstein malformation can have
uccessful biventricular repair. We now use the BCPS
electively in the setting of a severely enlarged and/or
everely dysfunctional RV. The BCPS is not performed
outinely because it compromises access to the heart for
lectrophysiologic evaluation and ablation and for pace-
aker lead placement, as seen in one of our patients. In
ddition, it may be associated with pulsations of the head
nd neck veins, facial suffusion, and the development of
ollateral veins and pulmonary arteriovenous fistulas.10
When a concomitant BCPS is performed at the time of
V replacement, blood flow through the TV is reduced.
herefore, it is important to place a TV prosthesis that is not
scharge
Hospital LOS Follow-up
osure 28 d None
6 d 78 mo
6 d 47 mo
4 d None
6 d 29 mo
5 d 10 d
tan takedown;
rawal of support
13 d Death from MOF with
fungal sepsis
5 d 24 d
8 d 29 d
prosthesis 11 d 21 mo
7 d 8 mo
12 d 5 mo
e 11 d None
cardial lead 15 d 3 mo
xygenation; IABP, intra-aortic balloon pump; LOS, length of stay; MOF,al di
al cl
; Fon
ithd
d TV
losur
; epi
ane oversized (ie, a valve that matches the reduced flow through
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Dhe right side of the heart) so that all the bioprosthetic
eaflets or mechanical discs open and close normally. Be-
ause we have occasionally noted decreased mobility of the
eaflets of bioprosthetic valves after the BCPS, we now
outinely anticoagulate with warfarin for a 3- to 6-month
eriod or until full mobility of all leaflets is demonstrated on
chocardiography. Aspirin, 81 mg daily, is continued there-
fter. The increased risk of thrombosis and need for antico-
gulation are potential disadvantages of a concomitant
CPS at repair of Ebstein anomaly.
Patients with Ebstein anomaly may have significant RV
ysfunction from longstanding TV regurgitation superim-
osed on a myopathic ventricle.17 Consequently, when the
V is significantly enlarged in the setting of severe TV
egurgitation, we believe it is important to reduce the re-
urgitation to no more than a mild or moderate degree after
V repair to prevent further RV dilatation or dysfunction
nd to optimize the possibility of favorable RV remodeling.
f this result cannot be obtained, it is our philosophy to then
roceed with TV replacement (usually porcine bioprosthe-
is) so that the volume load on the myopathic RV is as low
s possible. In our experience, the late results of TV re-
lacement are comparable with those of TV repair.4
Marianeschi and associates15 have suggested that the
onstruction of a BCPS in patients with mild TV regurgi-
ation may reduce the RV preload to a point where no
ntervention on the TV is required; patients with moderate
r severe TV regurgitation may have reductions in the
egurgitation that allow less aggressive TV interventions;
nd the BCPS may also allow more TV repair options that
ould result in iatrogenic TV stenosis in the absence of a
CPS. The creation of a BCPS may also decrease the
ncidence of reoperation for patients with residual TV re-
urgitation.14 There are insufficient data at the present time
o confirm the validity of these concepts. Nevertheless, we
avor sending the patient out of the operating room with a
ompetent TV.
Ventricular plication has often been performed during
epair of Ebstein anomaly. Our original ventricular plication
echnique (apex to base) results in a maximal reduction of
V size, but appeared to be associated with increased ven-
ricular rhythm disturbances.18 Currently, we reserve plica-
ion or resection for thin, transparent, or dyskinetic seg-
ents of the atrialized RV myocardium, most often seen in
he area of the inferior wall of the RV. Potential advantages
f plication or resection include a reduction in the size of the
onfunctional portion of the RV, which may improve the
ransit of blood through the right side of the heart and lessen
ompression on the LV (“pancake” effect), thus improving
V function. The disadvantages of RV plication or resection
nclude potential compromise of the coronary arterial sup-
ly to the RV and potential development of ventricular
rrhythmias. Although partial RV resection was performed s
The Journal of Thoracicn only 3 patients in this series, we now have a lower
hreshold to apply it to large areas of thinned atrialized
nferior RV. The resection is performed as an ellipse from
ase to apex, which brings the acute margin of the RV in
lose proximity to the posterior descending coronary artery.
his results in a suture line that is parallel to branches of the
ight coronary artery, thus minimizing coronary compro-
ise. When plication or resection is performed, antiarrhyth-
ic therapy (usually amiodarone) is used for approximately
months postoperatively.
Pharmacologic management at the time of separation
rom cardiopulmonary bypass includes routine use of epi-
ephrine and milrinone infusions. Lidocaine or amiodarone
herapy is used if there are any atrial or ventricular tachy-
rrhythmias present. Adjuncts to operation that we have also
pplied to this group of patients include a low threshold for
elayed sternal closure. Maneuvers to decrease RV after-
oad, (ie, decrease PAP) have included mild hyperventila-
ion, the selective use of nitric oxide, and intra-aortic bal-
oon counterpulsation, especially in adults with concomitant
epression of LV function.
Treatment of patients with Ebstein anomaly is the most
hallenging in those who have biventricular dysfunction.
hree patients in this series had depressed LVEF (35% in 2
nd 40% in 1). The function and geometry of the LV can be
ltered by dilated right-sided chambers.19 Quantification of
entricular function can be difficult if the LV is underfilled
nd compressed by a dilated RV; associated paradoxical
otion of the septum also makes it difficult to estimate the
VEF. After surgical repair, the postoperative LV function
mproved in each of these patients. This may be related to
etter diastolic filling after the volume load on the RV was
educed and/or an increase in LV preload provided by the
CPS.
The preoperative evaluation of a patient with depressed
V function may include a hemodynamic cardiac catheter-
zation to obtain pulmonary arterial and left-sided filling
ressures to ascertain that hemodynamics will be appropri-
te for the construction of a BCPS. Coronary angiography
ay be done at the same time. Heart transplantation is
eserved for those patients who have significant LV dys-
unction (LVEF 25%). Patients who have moderate depres-
ion (LVEF  40%) can usually undergo a conventional
peration (with or without a BCPS). The surgical management
f patients with an LVEF between 25% and 35% is the most
ifficult and is evolving, as we now are more likely to consider
he use of the BCPS. If hemodynamic catheterization confirms
he ability to perform a BCPS, we then proceed with a con-
entional operation that may include a BCPS. Intraoperative
irect pressure measurements are performed before a BCPS
s considered. This shunt is permissible in the setting of
epressed LV function provided the LV end-diastolic pres-
ure is less than 15 mm Hg, the transpulmonary gradient is
and Cardiovascular Surgery ● Volume 133, Number 5 1307
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Dess than 10 mm Hg, and the mean PAP is less than 18 to 20
m Hg.
Three patients in this series were initially referred for
ardiac transplantation. All were adults who had heart fail-
re with depressed LV function. One patient, who had an
VEF of 35%, had his medication regimen adjusted and his
entricular response to atrial fibrillation controlled. His
VEF improved to 55% before the operation. This demon-
trates the importance of an aggressive medical heart failure
egimen, which includes rhythm and rate control of atrial
achyarrhythmias, to optimize ventricular function. In pa-
ients with a history of atrial tachyarrythmias, it also under-
cores the importance of performing a maze procedure at
he time of operation to restore or maintain sinus rhythm
ostoperatively.3 The other 2 patients had LVEFs of 35%
nd 40%. The favorable outcome of these 3 patients after a
onventional operation with a BCPS implies that well-
elected patients may benefit from this approach. In addi-
ion, it appears that functional capacity improves in the short
erm, but longer follow-up is required to know whether
mprovements of LV function and functional capacity are
aintained. It is not known whether the BCPS will only
ridge these patients to heart transplantation.11
Another adjunct that can be applied to the surgical treat-
ent of patients with Ebstein anomaly and a failing RV is
he placement of an atrial septal fenestration or subtotal
losure of an atrial septal defect. This may be done in
eonatal patients whose elevated pulmonary resistance is a
ontraindication to a BCPS. However, in older patients, it
as been our experience that profound arterial desaturation
rom severe right-to-left shunting may occur in this setting.
onsequently, we now close all atrial septal defects com-
letely and use the BCPS as our main adjunct in this group
f patients.
tudy Limitations
his study was composed of a small number of patients with
nly midterm clinical follow-up and limited echocardio-
raphic follow-up. The patients were heterogeneous with
espect to age and clinical presentation, although this is
onsistent with the spectrum of Ebstein anomaly.
The ability to systematically and accurately report RV
ize and function by echocardiography can be difficult,20
specially in patients with Ebstein anomaly. The RV frac-
ional area change may underestimate the degree of RV
ysfunction when severe TV regurgitation is present. LV
unction can also be difficult to quantitate. We now obtain
agnetic resonance imaging studies to better quantitate the
ize and function of the atrialized and functional RV, espe-
ially in those patients with RV dysfunction.
This observational, nonrandomized study is limited to
ur experience with patients with Ebstein anomaly who had
BCPS constructed as part of their surgical treatment.
308 The Journal of Thoracic and Cardiovascular Surgery ● Maany of these patients underwent the creation of a BCPS in
nticipation of RV failure, and others had the shunt con-
tructed as a salvage procedure owing to hemodynamic
nstability. In the operations in which the shunt was
lanned, we can only assume, but cannot prove, that the
perative mortality was reduced by using the BCPS. Further
xperience is needed to identify which patients should un-
ergo BCPS as part of their repair. A randomized trial
ould be difficult to implement and power.
onclusions
t our institution, the use of the BCPS as an adjunct in the
urgical treatment of patients with Ebstein anomaly has
een infrequent and only recently employed. In patients
ith a severely enlarged or dysfunctional RV, we believe
he BCPS is an important and helpful adjunct to a standard
perative repair. The 1.5-ventricle repair may be planned in
nticipation of RV failure; it may be used as a salvage
rocedure for established RV failure; or it may help to
mprove depressed LV function and may be an alternative
or those patients being considered for heart transplantation.
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iscussion
r Vaughn A. Starnes (Los Angeles, Calif) [presented on Dr
tarnes’ behalf by Dr John Hawkins].
Dr John Hawkins. (Salt Lake City, UT). I am not going to try
o do my Vaughn Starnes impression this morning. I am substi-
uting for Vaughn, who could not be here today.
First of all, I congratulate Dr Quinonez on a nice presentation.
his is important not only for pediatric surgeons but for adult
urgeons as well, because many of these patients are not children.
hey are adults with Ebstein anomaly even though it is a congen-
tal defect. The Mayo group clearly has been the leader in the
reatment of Ebstein anomaly over the years, and we look to your
uidance frequently. I do, anyway, because you have so much
xperience. In the manuscript you reported about 640 patients who
ad undergone repair since 1972. By my calculations, I would be
bout 150 or 200 years old before I accumulated that experience,
o we need your guidance to tell us what to do. Most of my
uestions are going to center around the idea of using your expe-
ience to lessen my and our learning curve in treating these
atients.
From what I can determine (doing the math), between 1972 and
999 you treated 473 patients with Ebstein anomaly and never did
BCPS. Since 1999, you have treated 167 patients with Ebstein
nd 14 patients underwent BCPS. In the last 12 months, 8 of your
4 had undergone this procedure. Obviously, there is a little bit of
n epidemic of BCPS in Ebstein anomaly at the Mayo Clinic. My
uestion is, what has changed recently to force you or to have you
o more BCPSs? Have you changed, have the patients changed, or
s it a combination?
Dr Quinonez. The experience at Mayo Clinic for the treatment
f Ebstein anomaly has been extensive and has had good results,
ith mortality in the range of 5%. There has been no compelling
eason to introduce this new technique. However, in patients who
ere hemodynamically unstable in the operating room and were
nable to separate from cardiopulmonary bypass, it was used as a
alvage procedure and the results were remarkable. The patients f
The Journal of Thoracicere able to come off bypass. This led to the question: Can we use
his technique in patients who we expect are going to do poorly?
t was tried as a planned procedure.
I have looked after patients with poor RVs with and without
idirectional Glenn shunts. I can tell you that the postoperative
ourse is remarkably favorable with the Glenn. They are generally
ot easy patients to manage postoperatively in the intensive care
nit, but it is much easier to manage them with the Glenn. This has
ed to enthusiasm to apply it more widely in these patients. In
ddition, perhaps the referral pattern from the cardiologists is such
hat patients with more symptoms and severely dilated and dys-
unctional RVs are being referred to us.
Doctor. So it is a little bit of both perhaps. My second question
as to do with, again, helping us to choose when to do this
rocedure. The Mayo group has been a world leader in terms of
chocardiography and the criteria that we evaluate in terms of the
isplacement of the valve leaflets, the functional RV that is going
o be left when the operation is completed. This information is
sed to help determine who is going to be able to have a repair
ersus a replacement. In the manuscript you are using magnetic
esonance imaging criteria more frequently now to help you make
hese judgments, but you did not really go into any details. Do you
ave any tests, specifically magnetic resonance imaging criteria or
easurements, that you may look at to help you decide when you
re going to need to do a BCPS?
Dr Quinonez. That is difficult to answer because we are not
lear about this ourselves. As we gain experience with the shunt,
e are trying to decide what criteria we should use. Echocardiog-
aphy is routinely used, but this is problematic when measuring the
unction of the RV. We are now using magnetic resonance imaging
ore frequently because it is a more objective measurement and
e can compare preoperative and postoperative magnetic reso-
ance images.
The decision to use the shunt is multifactorial. It involves
linical judgment, with consideration of the clinical presentation of
he patient, the echocardiogram, and a cardiac catheterization in
atients with LV dysfunction. It also involves what the surgeon
ees in the operating room. These ventricles are enormous, and
ords such as “profoundly,” “massively,” and “enormous” are
sed, so all these contribute to the decision making. A lot of
linical judgment goes into it.
Doctor. My final question is relatively short. In my experience
oing a bidirectional Glenn or a BCPS in an adult is not straight-
orward. I have not done very many and I do not really like to
xplore that option too much, but many of your patients were
dults. How is this tolerated in the adult population? It is my
erhaps personal bias that it is not well tolerated in adults, but I
ould like to know how it was in these particular patients in terms
f postoperative morbidity and long-term functional results.
Dr Quinonez. We have 4 adult patients in this series and the
ollow-up is limited. The initial problem of facial suffusion and
acial pulsations we have not seen. In terms of long-term outcomes
n patients who have had Glenn procedures at Mayo Clinic, there
ave been problems with distended upper neck veins. That has
een an issue and a concern of some of the cardiologists, but these
eem to be exceptional problems. We do not have the length of
ollow-up to know what the long-term results are going to be.
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DDr John Nigro (Phoeniz, Ariz). Having struggled with some
f these patients and seen the success of the Glenn shunt, is
here any possibility that this may be definitive therapy or a
herapy that is used before intracardiac repair? In other words,
f a patient might benefit from unloading the RV, maybe an
ff-pump Glenn would be a suitable repair. It might at least buy
ou time to let a child grow or maybe get you through a
igh-risk period. Just a thought.
Dr Quinonez. I think it is a good point; however, you have to310 The Journal of Thoracic and Cardiovascular Surgery ● Mas the patient cyanotic because of an atrial septal defect? You are
oing to have to fix that. Does the patient have TV regurgitation?
f the patient has more than mild TV regurgitation, we would
ncourage you to fix that. In the face of TV regurgitation, the
yopathic and enlarging RV is going to suffer. Some have argued
hat by unloading the RV you may reduce TV regurgitation. We do
ot know whether this is in fact the case or for how long. It is a
ood idea and the Glenn may temporize; however, we would
ncourage you to repair the other lesions because these will even-onsider the other associated lesions and the clinical presentations. tually come back to haunt you and the patient.y 2007
